Clinical Trial Update: SCALp Cooling for pReventing aLopecia With nEw anTibody-drug Conjugates [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update describes a scalp cooling approach to prevent alopecia in patients receiving new antibody-drug conjugates for advanced or metast…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alopecia
• Or Metastatic Solid Tumors

Snippet

Sponsor: Jules Bordet Institute | Conditions: Advanced or Metastatic Solid Tumour, Antibody-Drug Conjugate | Phase 2 | Status: NOT_YET_RECRUITING